Table 1. Baseline characteristics of the patients enrolled.

Baseline Characteristics	Value, % (n = 20)
Age, median years (range)	72 (range 54–86)
Race: white/black/other (%)	65/20/15
Gleason Sum 8–10 (%)	50%
Karnofsky Score ≥90 (%)	65%
Visceral Metastases (%)	5%
Bone metastases (%) %>20 bone metastases	100% 65%
PSA ng/ml (median)	50 (range 2–1896)
Cellsearch CTCs ≥5	75%
Visual Analogue Pain Scale 4–10, opiate use%	30%, 30%
Denosumab or zoledronic acid use	85%
Alkaline phosphatase IU/dl median (range) Alkaline phosphtase %>ULN	119 (41–551) 55%
Prior docetaxel/enzalutamide/abiraterone	50/95/80%